Form D — 20/20 Biolabs, Inc.
0001786236-25-000007 · filed Feb 26, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $3,000,000
- Reported amount sold
- $70,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- 20/20 Biolabs, Inc.
- CIK
- 1139685
- Entity
- Corporation
- Jurisdiction
- Delaware
- Year incorporated
- 2000
- Address
- 15810 GAITHER ROAD, SUITE 235
GAITHERSBURG, Maryland 20877 - Phone
- —
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jonathan Cohen · Executive OfficerGaithersburg, Maryland Find on LinkedIn ↗
-
Anne Shiflett · Executive OfficerGaithersburg, Maryland Find on LinkedIn ↗
-
Jiminy Zhou · Executive OfficerGaithersburg, Maryland Find on LinkedIn ↗
-
John G Compton · DirectorGaithersburg, Maryland Find on LinkedIn ↗
-
Wei Lu · DirectorGaithersburg, Maryland Find on LinkedIn ↗
-
Prasanth Reddy · DirectorGaithersburg, Maryland Find on LinkedIn ↗
-
John W. Rollins · DirectorGaithersburg, Maryland Find on LinkedIn ↗
-
Michael A Ross · DirectorGaithersburg, Maryland Find on LinkedIn ↗
-
Richard M. Cohen · DirectorGaithersburg, Maryland Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗